These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7483136)

  • 1. Oral and topical treatment of erectile dysfunction. Present and future.
    Morales A; Heaton JP; Johnston B; Adams M
    Urol Clin North Am; 1995 Nov; 22(4):879-86. PubMed ID: 7483136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in oral therapy for erectile dysfunction.
    Seftel AD
    J Androl; 2002; 23(6):729-36. PubMed ID: 12399513
    [No Abstract]   [Full Text] [Related]  

  • 3. [Topical therapy in erectile dysfunction].
    Floth A
    Wien Med Wochenschr; 2000; 150(1-2):14-7. PubMed ID: 10746290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on oral treatments for male erectile dysfunction.
    Kalsi JS; Kell PD
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy.
    Sexton WJ; Benedict JF; Jarow JP
    J Urol; 1998 Mar; 159(3):811-5. PubMed ID: 9474156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual apomorphine: new preparation. In erectile disorders: a narrow therapeutic margin.
    Prescrire Int; 2002 Jun; 11(59):76-9. PubMed ID: 12068841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline penile erection induced by topical glans penis application of combination alprostadil and SEPA (Topiglan).
    Usta MF; Sanabria J; Bivalacqua TJ; Hellstrom WJ
    Int J Impot Res; 2004 Feb; 16(1):73-7. PubMed ID: 14963475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
    Bratus D; Hlebic G; Hajdinjak T
    Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apomorphine and erectile dysfunction].
    Tan DQ; Yao Y; Zhang J
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and transcutaneous pharmacologic agents in the treatment of impotence.
    Morales A; Condra MS; Owen JE; Fenemore J; Surridge DH
    Urol Clin North Am; 1988 Feb; 15(1):87-93. PubMed ID: 3125645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of erectile dysfunction: what are the objectives and the methods?].
    Bondil P; Blachère P
    Prog Urol; 1998 Feb; 8(1):17-31. PubMed ID: 9533148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apomorphine to Uprima: the development of a practical erectogenic drug: a personal perspective.
    Morales A
    Int J Impot Res; 2001 Aug; 13 Suppl 3():S29-34. PubMed ID: 11477489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy in erectile dysfunction agents for self-injection programs and alternative application models.
    Hedlund H; Hedlund P
    Scand J Urol Nephrol Suppl; 1996; 179():129-38. PubMed ID: 8908679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erectile dysfunction. An update].
    Wagner G; Saenz de Tejada I
    Ugeskr Laeger; 1999 Mar; 161(9):1243-8. PubMed ID: 10083818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer phosphodiesterase inhibitors: comparison with established agents.
    McNamara ER; Donatucci CF
    Urol Clin North Am; 2011 May; 38(2):155-63. PubMed ID: 21621082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction.
    Padma-Nathan H; Goldstein I; Klimberg I; Coogan C; Auerbach S; Lammers P;
    Int J Impot Res; 2002 Aug; 14(4):266-70. PubMed ID: 12152116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment and future perspectives for erectile dysfunction.
    Hatzichristou DG
    Int J Impot Res; 1998 May; 10 Suppl 1():S3-13. PubMed ID: 9669215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erectile dysfunction].
    Lyngdorf P
    Ugeskr Laeger; 2002 Oct; 164(41):4779-83. PubMed ID: 12407881
    [No Abstract]   [Full Text] [Related]  

  • 20. [Viagra is first choice preparation in the treatment of erectile dysfunction. Access to a variety of methods makes individual treatment possible].
    Hedelin H; Jacobsson L
    Lakartidningen; 2000 May; 97(21):2616-7. PubMed ID: 10881522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.